Evidence map›Paper›PMID 34315227›Full record

ArticleJournal of the American Heart Association2021

Penetrance of Severe Pulmonary Arterial Hypertension in Response to Vascular Endothelial Growth Factor Receptor 2 Blockade in a Genetically Prone Rat Model Is Reduced by Female Sex.

Ketul R Chaudhary, Yupu Deng, Anli Yang, Nicholas D Cober, Duncan J Stewart

Open access · goldAbstract readComparative Study
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Mechanisms of lung endothelial cell injury and survival in pulmonary arterial hypertension.American journal of physiology. Lung cellular and molecular physiology · 2024
    Review
  6. Article
  7. Role of Sensory Nerves in Pulmonary Fibrosis.International journal of molecular sciences · 2024
    Review
  8. Pericytes: The lung-forgotten cell type.Frontiers in physiology · 2023
    Review
  9. Circulation research · 2022
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ketul R ChaudharyDepartment of Physiology and Biophysics Faculty of Medicine Dalhousie University Halifax NS Canada.
Yupu DengSinclair Centre for Regenerative Medicine Ottawa Hospital Research Institute ON Canada.
Anli YangSinclair Centre for Regenerative Medicine Ottawa Hospital Research Institute ON Canada.
Nicholas D CoberSinclair Centre for Regenerative Medicine Ottawa Hospital Research Institute ON Canada.
Duncan J StewartSinclair Centre for Regenerative Medicine Ottawa Hospital Research Institute ON Canada.
Ottawa Hospital · CAUniversity of Ottawa · CADalhousie University · CA

Funding

CIHR FDN – 143291CIHR SVB‐145555
6 · The paper itself

Abstract

Background We have previously reported important strain differences in response to SU5416 (SU, a vascular endothelial growth factor receptor 2 inhibitor) in rats and have identified a specific colony of Sprague-Dawley rats that are hyperresponsive (SD

Indexed as

ApoptosisIndolesPenetrancePyrrolesAnimalsDisease Models, AnimalEndothelial CellsEstradiolEstrogen Replacement TherapyFemaleGenetic Predisposition to DiseaseGonadal Steroid HormonesMaleOvariectomyPhenotypeProgesteroneEstradiolGonadal Steroid HormonesIndolesKdr protein, ratProgesteronePyrrolesSemaxinibVascular Endothelial Growth Factor Receptor-2disease penetranceendothelial cell apoptosisestrogen paradoxpulmonary arterial hypertensionsex hormones

Identifiers

PMID34315227
PMCPMC8475703
OpenAlexW3184652546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.